^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Waldenstrom Macroglobulinemia |
| Drug: | Venclexta (venetoclax) (Bcl2 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
12/07/2021
Excerpt:
Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma...Other recommended regimens...Venetoclax
